ALO1567 (AL1567) is an orally available aldose reductase inhibitor with an IC50 of 27 nM for rat lens aldose reductase. ALO1567 can be used in the research of diabetes[1].
References
[1] Griffin, et al. "Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats." Metabolism 36.5 (1987): 486-490. DOI:10.1016/0026-0495(87)90048-5
